{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:59:42Z","timestamp":1765609182733},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":692,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:p>The aim of this study was to establish how effective is the use of immunohistochemistry on formalin\u2010fixed bone marrow in diagnosing low\u2010grade B\u2010cell neoplasms. We investigated a series of 41 consecutive patients with bone marrow involvement for whom no other diagnostic tissues were available. The sections were stained with the following antibodies: CD3, CD20, CD79a, CD5, CD10, CD23, anti\u2010cyclin D1 and kappa and lambda light chains. Antigen retrieval was performed using either a microwave oven or a pressure cooker. Labelling was performed with an avidin\u2013biotin\u2013peroxidase labelling system. A final diagnosis was reached in 37 out of 41 cases (90%): B\u2010chronic lymphocytic leukaemia (15 cases), follicular lymphoma (10 cases), mantle\u2010cell lymphoma (eight cases) and lymphoplasmacytoid lymphoma\/immunocytoma (four cases). In the remaining four cases, a generic diagnosis of low\u2010grade B\u2010cell neoplasm was made. The immunophenotyping of formalin\u2010fixed marrow is a useful technique for diagnosing most of the low\u2010grade B\u2010cell neoplasms.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01844.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:21:45Z","timestamp":1047363705000},"page":"369-376","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The diagnosis of low\u2010grade peripheral B\u2010cell neoplasms in bone marrow trephines"],"prefix":"10.1111","volume":"108","author":[{"family":"Pezzella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Munson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Goldstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Gatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608874"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02969.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711720303"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.52"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19971021)74:5<556::aid-ijc14>3.0.co;2-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.7.2715.2715"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2726.2726"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711710205"},{"key":"e_1_2_6_10_2","first-page":"1927","article-title":"Rituximab (anti\u2010CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicentre phase II study","volume":"92","author":"Coiffier B.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.17.12.7362"},{"key":"e_1_2_6_12_2","unstructured":"Gatter K.&Brown D.(1997)An Illustrated Guide to Bone Marrow Diagnosis. Blackwell Science Oxford."},{"key":"e_1_2_6_13_2","first-page":"59","article-title":"Chemoimmunotherapy of low grade lymphoma with anti\u2010CD20 antibody IDEC\u2010C2B8 in combination with CHOP chemotherapy","volume":"14","author":"Grillo\u2010Lopez A.","year":"1996","journal-title":"Cancer Investigation"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/ajcp\/101.3.305","article-title":"Bone marrow involvement in large\u2010cell lymphoma. Prognostic implications of discordant disease","volume":"101","author":"Hodges G.F.","year":"1994","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.19","article-title":"Fludarabine; a new agent with major activity against chronic lymphocytic leukemia","volume":"74","author":"Keating M.J.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.748"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199808000-00008"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19980610)76:6<806::aid-ijc7>3.0.co;2-1"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood.V91.8.2955.2955_2955_2960","article-title":"The clinical significance of molecular response in indolent follicular lymphoma","volume":"91","author":"Lopez\u2010Guillermo A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_21_2","first-page":"707","article-title":"Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines","volume":"9","author":"Lukas J.","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_6_22_2","first-page":"2125","article-title":"Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types","volume":"10","author":"Lukas J.","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-3-199602010-00005"},{"key":"e_1_2_6_24_2","first-page":"268","article-title":"Optimising Cyclin D1 immunostaining of mantle cell lymphoma","volume":"34","author":"Miller K.D.","year":"1999","journal-title":"Histopathology"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711740410"},{"key":"e_1_2_6_26_2","first-page":"536","article-title":"Immunostaining of PRAD1\/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma","volume":"11","author":"Nakamura S.","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711730413"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01366.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.1.2"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.6.1177"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/39.6.1709656"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.1.16"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","unstructured":"Solal\u2010Celigny P.(1996) Management of histologically indolent non\u2010Hodgkin's lymphomas. In:Non\u2010Hodgkin's Lymphomas. Balliere's Clinical Haematology(ed. by D.C. Linch)9 669687. Bailli\u00e8re Tindall London.","DOI":"10.1016\/S0950-3536(96)80048-5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90090-X"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.52.4.294"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.5.582"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/108.3.302"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/100.4.373"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01844.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01844.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01844.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:20:07Z","timestamp":1698567607000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01844.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01844.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01844.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}